维普中文期刊产品整合服务
17篇 您的检索式:作者名="Hawles"
    题名 作者 年代 出处 被引量
1Conversion of Glycerol to 1,3-Propanediol via Selective Dehydroxylation 显示文摘Wang K Y Hawle M C Deathos S J 2003Ind Eng Chem Res2003,42,13:1
2Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors:final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) 显示文摘PEREYL PAR IDAENS R HAWLE H 2007Ann Oncoi2007,18,64:1
3The middle domain of Hsp90 acts as a discriminator between different types of client proteins显示文摘Hawle P Siepmann M Harst A 2006Mol Cell Biol2006,26,22:1
4The need and plan for global limination of congenital syphilis显示文摘Schmid GP Stoner BP Hawles S 0,,7:1
5Early transplanting system tested in south Korea显示文摘 1999Tobacco Journal Internationl1999,36,1:1
6Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors:final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial显示文摘Perey L Paridaens R Hawle H 2007Ann Oncol2007,18,1:1
7The need and plan for global elimination of congenital syphilital显示文摘Schmid G P Stonger B P Hawles S 2007Sex Transm Sis2007,34,7:1
8Cdc37p is required for stress-induced high-osmolarity glycerol and protein kinase C mitogen-activated protein kinase pathway functionality by interaction with Hog1p and Slt2p (Mpk1p) 显示文摘Hawle P Horst D Bebelman J P Yang X X Siderius M der Van V 2007Eukaryotic Cell2007,6,3:1
9The middle domain of Hsp90 acts as a discriminator between different types of client proteins显示文摘Hawle P Siepmann M Harst A 2006Mol Cell Biol2006,26,22:1
10Cdc37p is required for stress-induced high-osmolarity glycerol and protein kinase C mitogen-activated protein kinase pathway functionality by interaction with Hoglp and Slt2p (Mpk1p)显示文摘Hawle P Horst D Bebelman J P 2007Eukaryotic Cell2007,6,:1
11Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial experience显示文摘Hija ZM Haki MF Hawl HAA 2002Catheter Cardiovasc Interv2002,56,:1
12Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors:final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial显示文摘Perey L Paridaens R Hawle H 2007Ann Oncol2007,,18:1
13Cdc37p is required for stress- induced high-osmolarity glycer61 and protein kinase C mitogen-acti- vated protein kinase pathway functionality by interaetion with Hoglp and Slt2p ( Mpkl p) 显示文摘Hawle P Horst D Bebelman J P 2007Eukaryot Cell2007,6,:1
14Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) 显示文摘PEREY L PARIDAENS R HAWLE H 2007Ann Oncol2007,18,:1
15Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial显示文摘Perey L Paridaens R Hawle H 2006Ann Oncol2006,10,:1
16Clinical benefit of fulvcs- trant in postmcnopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) 显示文摘Percy L Paridaens R Hawle H 2007Ann Oncol2007,18,1:1
17Conversion of glycerol to 1,3-propanediol via selective dehydroxylation 显示文摘WANG K Y MARTIN C HAWLE Y 2003Ind Eng Chem Res2003,42,13:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费